The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant

BACKGROUND: Rapastinel (GLYX-13) is a NMDA receptor modulator with glycine-site partial agonist properties. It is a robust cognitive enhancer and shows rapid and long-lasting antidepressant properties in both animal models and in humans. METHODS: Rapastinel was derived from a monoclonal antibody, B6...

Descripción completa

Detalles Bibliográficos
Autores principales: Moskal, Joseph R., Burgdorf, Jeffrey S., Stanton, Patric K., Kroes, Roger A., Disterhoft, John F., Burch, Ronald M., Khan, M. Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327451/
https://www.ncbi.nlm.nih.gov/pubmed/26997507
http://dx.doi.org/10.2174/1570159X14666160321122703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327451/
https://www.ncbi.nlm.nih.gov/pubmed/26997507
http://dx.doi.org/10.2174/1570159X14666160321122703

Ejemplares similares